AEGLEA BIOTHERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by AEGLEA BIOTHERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-04-25Fairmount Funds Management LLCSpyre Therapeutics, Inc.4,024,54110.0%EDGAR
SC 13G/A2024-04-23Avoro Capital Advisors LLCSpyre Therapeutics, Inc.1,839,1385.1%EDGAR
SC 13G/A2024-03-11FMR LLCSpyre Therapeutics, Inc.6,584,17518.2%EDGAR
SC 13G/A2024-02-14Logos Global Management LPSpyre Therapeutics, Inc.150,0000.4%EDGAR
SC 13G/A2024-02-14EcoR1 Capital, LLCSpyre Therapeutics, Inc.887,0762.5%EDGAR
SC 13G/A2024-02-14BAKER BROS. ADVISORS LPSpyre Therapeutics, Inc.-0.0%EDGAR
SC 13G/A2024-02-14Nantahala Capital Management, LLCSpyre Therapeutics, Inc.00.0%EDGAR
SC 13G/A2024-02-14Venrock Healthcare Capital Partners III, L.P.Spyre Therapeutics, Inc.3,734,51410.0%EDGAR
SC 13G/A2024-02-14Deep Track Capital, LPSpyre Therapeutics, Inc.2,184,4406.0%EDGAR
SC 13G/A2024-02-14Rock Springs Capital Management LPSpyre Therapeutics, Inc.00.0%EDGAR
SC 13G/A2024-02-14PERCEPTIVE ADVISORS LLCSpyre Therapeutics, Inc.2,606,6797.2%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPSpyre Therapeutics, Inc.1,934,0845.4%EDGAR
SC 13G2024-02-14RTW INVESTMENTS, LPSpyre Therapeutics, Inc.2,232,7606.2%EDGAR
SC 13G2024-02-14Avoro Capital Advisors LLCSpyre Therapeutics, Inc.2,125,5975.9%EDGAR
SC 13G/A2024-02-13SUVRETTA CAPITAL MANAGEMENT, LLCSpyre Therapeutics, Inc.412,3951.0%EDGAR
SC 13G/A2024-02-13Polar Capital Holdings PlcSpyre Therapeutics, Inc.500,0001.0%EDGAR
SC 13G/A2024-02-13BCLS II Equity Opportunities, LPSpyre Therapeutics, Inc.00.0%EDGAR
SC 13G/A2024-02-13Affinity Asset Advisors, LLCSpyre Therapeutics, Inc.653,4091.8%EDGAR
SC 13G/A2024-02-12FMR LLCSpyre Therapeutics, Inc.6,206,45113.1%EDGAR
SC 13G2024-02-09FMR LLCSpyre Therapeutics, Inc.3,785,8778.0%EDGAR
External links